Neoantigen vaccines offer a more personalized and precise approach to cancer treatment. Their high specificity reduces the likelihood of off-target effects and minimizes damage to healthy tissues. Additionally, since the immune system can be trained to recognize these unique peptides, there is potential for long-lasting protective immunity against cancer recurrence.
